Delivery Order SPE2DB22D1017-SPE2DB25FG6VE
- Not listed
- This federal contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,259.11, is for the delivery of the medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,088.36, is for the delivery of the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,369.15 firm fixed price delivery order is for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a specialty medication. The contract has an ultimate completion date of December 17, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract, valued at $2,840.15, is a Firm Fixed Price Delivery Order with an ultimate completion date of September 10, 2024. It is not set aside for any specific business category. Amerisourcebergen Drug Corp has a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,632.54 firm-fixed-price delivery order is for the medication MOUNJARO 5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- This federal contract award, valued at $10,052.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML, a pharmaceutical product, with a completion date of April 18, 2025. The contract is a firm fixed-price arrangement without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,360.45, is a delivery order for the supply of the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 7, 2025 and is a firm fixed price contract. AmerisourceBergen is the prime contractor, and there is no set-aside designation for this award. The...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,436.90 Firm Fixed Price delivery order is for the drug MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. The contract has an ultimate completion date of January 28, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,088.36 firm fixed price delivery order is for the supply of MOUNJARO 5 MG/0.5 ML PEN 0.5ML, a prescription medication. The contract has an ultimate completion date of July 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,054.15 firm fixed-price delivery order is for the medication MOUNJARO 2.5 MG/0.5 ML PEN 0.5ML, with a completion date of May 7, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG6VEDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,914.07, is a delivery order for the medication MOUNJARO 7.5 MG/0.5 ML PEN 0.5ML. It is a firm fixed-price contract with a completion date of July 9, 2025. The contract is not set aside and is an open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This award positions Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/8/25 |